학술논문

mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study.
Document Type
article
Source
Subject
mRNA COVID-19 vaccine-associated myopericarditis
outcomes
survey
variability
Adolescent
COVID-19
COVID-19 Vaccines
Humans
Myocarditis
RNA
Messenger
Language
Abstract
In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions.